
17 OFFICES
In 6 countries, giving us local insights across the globe
In 6 countries, giving us local insights across the globe
Our large, diverse data assets drive unique insights
We have 275+ specialized industry analysts, analytics and disease experts
We’ve consistently collaborated with our top 10 customers for more than 10 years
We began as a business with one vision: to provide healthcare and medical organizations with the data and guidance they need to bring powerful, life-changing therapies to more patients around the world. And we believe the best way to achieve the most constructive insight is through unity; we built our business around this principle.
In 2016, we merged thirteen discrete intelligence and data brands, with unity front-of-mind. Our company culture encourages our experts to collaborate, cross-polinate, and share their different perspectives to generate genuinely unique insights and profound solutions to problems.
Every client is a partner to us, and we work hard to help them transform the lives of patients and drive maximum return on commercial investments. Whether our clients rely on our syndicated research, or need a custom services engagement, our very best experts are always available to answer their call. We provide support far beyond simple project deliverables because we’re passionate about what we do.
Our data and our people are constantly uncovering insight on every facet of the healthcare industry. Read our latest citations and announcements.
Decision Resources Group (DRG) has evolved from a group of pioneering healthcare data, research, technology, and consulting companies. Now, we’re a singular, unified team that is focused on solving the most complicated challenges in world health management.
We are part of Clarivate, a global leader in providing trusted insights and analytics to accelerate the pace of innovation.
In-depth primary and secondary research on diseases, trends, emerging developments, and market potential of the drug industry. Companies turned to Decision Resources for the information, advice, and consultation they needed to license, market, and compete.
Managed care data and analysis from experts embedded in their local markets.
HealthLeaders-Interstudy analysts examined health plans, specific geographic healthcare markets, and the managed Medicare and Medicaid markets. Their databases and reports gave healthcare businesses the tools for strategic and tactical planning.
Formerly a singular leading provider of strategic information to the healthcare sector. Focused on devices, pharmaceuticals, and biotech, MRG gave clients access to specialized industry expertise through published reports, comprehensive databases, and customized consulting.
Served the market intelligence needs of the pharmaceutical and diagnostic imaging industries. With offices in Malvern, PA, and Brussels, Belgium, and affiliates in Tokyo, Seoul, and Shanghai, AMR published syndicated diagnostic imaging audits for clients across the globe.
Offered a high quality, comprehensive, and integrated database of formulary information in the United States. It covered virtually all commercial, Medicare, Medicaid, and PBM plans. Their services allowed pharmaceutical brands to leverage managed care formulary information to get competitive advantage.
Distinctive market research and advisory services focused on the intersection of technology and healthcare. Bringing clarity to the market forces, trends, and impacts of physician and consumer use of next generation digital media, through analysis of proprietary data sets, analysts uncovered valuable insights to strategically plan and market therapies.
Syndicated and custom market research for pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.
Consulting and market research services firm that focused on issues related to reimbursement and organized customer segments for biopharmaceutical manufacturers. PharmaStrat delivered strategic perspectives and market insight solutions to address challenges and opportunities for portfolio and pipeline products.
Founded in 1995, its services evolved over time to meet the increasing need for health economic and evidence-based solutions. Their vast experience across a wide range of disease areas was second to none.
Delivered high quality, managed markets-specific, business and training solutions to pharmaceutical and biotech businesses.
Life-sciences trend analytics and asset comparison software provider that provided business intelligence to validate opportunities, discover new assets, and assess competition.
An analytics platform which delivered unique, actionable insights that had a direct, measurable impact on: marketing campaigns, customer acquisition and retention programs, health systems’ physician alignment efforts, fraud and risk detection initiatives, and much more.
As a division of DRG, HBI continues to provide best-practice research, training, and services to more than 1,400 hospitals across the U.S. HBI helps clients to understand how best to address today’s most critical issues, with a focus on providing actionable solutions leading to significantly enhanced performance.
Provided highly-structured European and American Hospital Register, surgery statistics, and inpatient information to help brands launch new medical products, develop a full sales and marketing strategy, and understand the competitive landscape.
Introduced a novel innovation to the industry by building a data model that linked global regulatory and health technology assessment data to detailed clinical trial data, creating a platform for answering complex market access questions quickly using structured data.
Clarivate and DRG combine to support customers’ needs and deliver value across the entire drug, device and medical technology lifecycle.
In-depth primary and secondary research on diseases, trends, emerging developments, and market potential of the drug industry. Companies turned to Decision Resources for the information, advice, and consultation they needed to license, market, and compete.
Managed care data and analysis from experts embedded in their local markets.
HealthLeaders-Interstudy analysts examined health plans, specific geographic healthcare markets, and the managed Medicare and Medicaid markets. Their databases and reports gave healthcare businesses the tools for strategic and tactical planning.
Formerly a singular leading provider of strategic information to the healthcare sector. Focused on devices, pharmaceuticals, and biotech, MRG gave clients access to specialized industry expertise through published reports, comprehensive databases, and customized consulting.
Served the market intelligence needs of the pharmaceutical and diagnostic imaging industries. With offices in Malvern, PA, and Brussels, Belgium, and affiliates in Tokyo, Seoul, and Shanghai, AMR published syndicated diagnostic imaging audits for clients across the globe.
Offered a high quality, comprehensive, and integrated database of formulary information in the United States. It covered virtually all commercial, Medicare, Medicaid, and PBM plans. Their services allowed pharmaceutical brands to leverage managed care formulary information to get competitive advantage.
Distinctive market research and advisory services focused on the intersection of technology and healthcare. Bringing clarity to the market forces, trends, and impacts of physician and consumer use of next generation digital media, through analysis of proprietary data sets, analysts uncovered valuable insights to strategically plan and market therapies.
Syndicated and custom market research for pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.
Consulting and market research services firm that focused on issues related to reimbursement and organized customer segments for biopharmaceutical manufacturers. PharmaStrat delivered strategic perspectives and market insight solutions to address challenges and opportunities for portfolio and pipeline products.
Founded in 1995, its services evolved over time to meet the increasing need for health economic and evidence-based solutions. Their vast experience across a wide range of disease areas was second to none.
Delivered high quality, managed markets-specific, business and training solutions to pharmaceutical and biotech businesses.
Life-sciences trend analytics and asset comparison software provider that provided business intelligence to validate opportunities, discover new assets, and assess competition.
An analytics platform which delivered unique, actionable insights that had a direct, measurable impact on: marketing campaigns, customer acquisition and retention programs, health systems’ physician alignment efforts, fraud and risk detection initiatives, and much more.
As a division of DRG, HBI continues to provide best-practice research, training, and services to more than 1,400 hospitals across the U.S. HBI helps clients to understand how best to address today’s most critical issues, with a focus on providing actionable solutions leading to significantly enhanced performance.
Provided highly-structured European and American Hospital Register, surgery statistics, and inpatient information to help brands launch new medical products, develop a full sales and marketing strategy, and understand the competitive landscape.
Introduced a novel innovation to the industry by building a data model that linked global regulatory and health technology assessment data to detailed clinical trial data, creating a platform for answering complex market access questions quickly using structured data.